Stifel Financial Corp Pulmonx Corp Transaction History

Stifel Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.92 - $17.35 $70,651 - $249,146	14,360 New	14,360 $121,000
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $117,740 - $235,059	-8,410 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$21.13 - $35.65 $36,766 - $62,031	1,740 Added 26.09%	8,410 $209,000
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $11,293 - $17,138	-380 Reduced 5.39%	6,670 $214,000
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $7,555 - $9,340	210 Added 3.07%	7,050 $254,000

Q2 2021 Aug 13, 2021	BUY	$37.61 - $48.0 $257,252 - $328,320	6,840 New	6,840 $302,000

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.